Cinnamamide, an antitumor agent with low cytotoxicity acting on matrix metalloproteinase

Anti-Cancer Drugs

Volumn 11, Issue 1, 2000, Pages 49-54

  Jiang, Xiao feng ^a   Zhen, Yong su ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Antitumor agent; Cinnamamide; Matrix metalloproteinase inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; CINNAMAMIDE; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME REGULATION; FETUS LUNG; FIBROSARCOMA; HEPATOMA CELL; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; ZYMOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CINNAMATES; DISEASE MODELS, ANIMAL; HUMANS; KB CELLS; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0034109944     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200001000-00008     Document Type: Article

References (19)

1. 1. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix: role of matrix metalloproteinase in tumor invasion and metastasis. FASEB J 1993; 7: 1434-41.
2. 2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
3. 3. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs 1997; 15: 61-75.
4. 4. Bernhard EJ, Muschel RJ, Hughes EN. Mr 92000 gelatinase release correlates with the metastatic pheno-type in transformed rat embryo cells. Cancer Res 1990; 50: 3872-7.
5. 5. Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon and breast cancer. Cancer Res 1993; 53: 140-6.
6. 6. Levy TD, Cioce V, Sobel ME, et al. Increased expression of the Mr 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res 1991; 51: 439-44.
7. 7. Sawaya R, Yamamoto M, Gokaslan ZL, et al. Expression and localization of 72-kDa type IV collagenase (MMP-2) in human malignant gliomas in vitro. Clin Exp Metastasis 1996; 14: 35-42.
8. 8. Taraboletti G, Garofalo A, Belotti D, et al. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinase. J Natl Cancer Inst 1995; 87: 293-8.
9. 9. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993; 53: 2087-91.
10. 10. Waston SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD. Inhibition of organ invasion by matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcioma metastasis models. Cancer Res 1995; 55: 3629-33.
11. 11. Drummond AH, Beckett P, Bone EA, et al. BB-2516: an orally bioavailable matrix metalloproteinase inhibitor with efficacy in animal cancer models. Proc Am Ass Cancer Res 1995; 36: 100.
12. 12. Zhen YS, Su J, Xue YC, Qi CQ, Hu JL. Novel nucleoside transport inhibitors of natural origin. Adv Exp Med Biol 1994; 370: 779-82.
13. 13. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-42.
14. 14. Cao SS, Zhen Y-s. Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B. Cancer Chemother Pharmacol 1989; 24: 181-6.
15. 15. Santos O, McDermott CD, Daniels RG, Appell K. Rodent pharmacokinetic and antitumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinase. Clin Exp Metastasis 1997; 15: 499-508.
16. 16. Ata N, Oku T, Hattori M, Fujii H, Nakajima M, Saiki I. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagenase by metastasis rumor cells. Oncol Res 1996; 8: 503-11.
17. 17. Liu L, Hudgins WR, Shack S, Yin MQ, Samid D. Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer 1995; 62: 345-50.
18. 18. Welch DR, Harper DE, Yohem KH. U-77863, a novel cinnamamide isolated from Streptomycetes griseolutous that inhibits cancer invasion and metastasis. Clin Exp Metastasis 1993; 11: 201-12.
19. 19. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.